production and evaluation of toxoplasma gondii recombinant sur­face antigen 1 (sag1) for serodiagnosis of acute and chronictoxop­lasma infection in human sera

background: the assays currently available for the detection of specific anti- toxoplasma antibodies may vary in their abilities to detect serum immunoglobulins, due to the lack of a purified standardized antigen. the aim of this study was evaluation the recombinant toxoplasma gondii sag1 antigen for the serodiagnosis of acute and chronic toxoplasmosis. methods : this study describes an elisa using recombinant sag1 for detection of igm and igg antibodies against toxoplasma gondii in human sera. genomic dna of t. gondii (rh strain) was isolated and pcr reaction was performed. recovered dna was cloned into ptz57r cloning vector. the recombinant plasmid was detected by restriction analysis. the sag1 gene was subcloned in the pet- 28a expression vector. protein production was then induced with 1 mm isopropyl-d - thiogalactopyrano­side (iptg). a total of 204 sera were tested using a commercial igg and igm elisa kit (trinity, usa) as gold standard prior to testing them with the recombinant antigen. results : tested sera were divided into the following groups:(a) the 74 t. gondii igg positive (b) 70 t.gondii igm positive (c) 60 sera who had no serological evidence of toxoplasmosis as negative sera.to determine the specificity of the test, we used other parasitic diseases including echinococusis (n=5), malaria (n=14), leishmania­sis (n=7),fasciolasis (n=4 ), sterengyloidiasis (n=1 ). sensitivity and specificity of the generated recombinant igg elisa in comparison with commercial elisa (com elisa) were 93% and 95%, and the sensitivity and specificity of the generated recombinant igm elisa were 87% and 95% respectively. conclusion: the results acquired here show that this antigen is useful for diagnostic purposes and could be replaced by lysed, whole cell antigens for diagnosis of chronic toxoplasmosis.